Diagnostic Performance of [<sup>18</sup>F]FDG PET in Staging Grade 1–2, Estrogen Receptor Positive Breast Cancer

Diagnostic Performance of [<sup>18</sup>F]FDG PET in Staging Grade 1–2, Estrogen Receptor Positive Breast Cancer

Positron emission tomography using [<sup>18</sup>F]fluorodeoxyglucose (FDG PET) potentially underperforms for staging of patients with grade 1–2 estrogen receptor positive (ER+) breast cancer. The aim of this study was to retrospectively investigate the diagnostic accuracy of FDG PET in...

Full description

Bibliographic Details
Main Authors: Ramsha Iqbal, Lemonitsa H. Mammatas, Tuba Aras, Wouter V. Vogel, Tim van de Brug, Daniela E. Oprea-Lager, Henk M. W. Verheul, Otto S. Hoekstra, Ronald Boellaard, Catharina W. Menke-van der Houven van Oordt
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Diagnostics
Subjects:
positron emission tomography (PET)
[<sup>18</sup>F]FDG
breast cancer
estrogen receptor
staging
Online Access:https://www.mdpi.com/2075-4418/11/11/1954

Internet

https://www.mdpi.com/2075-4418/11/11/1954

Similar Items